Authors



Evangelia Gkaragkani, MD, FEBOophth

Latest:

Monitoring glaucoma progression rate to preserve patients’ vision

Three approaches to examination give a comprehensive overview


By Lynda Charters; Reviewed by Sumit Garg, MD, ABO

Latest:

Magnetic cell therapy for corneal endothelial dysfunction

Phase 1 multicentre study data demonstrate early signs of efficacy


Renato Ambrósio Jr, MD, PhD

Latest:

Artificial intelligence for the early detection of ectatic corneal diseases

One of AI’s most promising applications: new diagnostic algorithms


Sharon Fekrat, MD, FASRS

Latest:

Retinal imaging to detect Alzheimer disease: machine learning model

An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.


Farhad Hafezi, MD, PhD, FARVO

Latest:

Going for gold: The new standard for cross-linking

Stabilising keratoconus and improving vision using ELZA-PACE customised CXL


Sunil Shah, MBBS, FRCS(Ed), FRCOphth, FBCLA, FWCRS

Latest:

The future of microbial keratitis treatment is bright

Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis


Dr Szilárd Kiss

Latest:

Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment safer

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.



Viha Vig

Latest:

ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis

Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia




Prof. Bora M Eldem

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Kathryn A. Colby, MD, PhD

Latest:

Novel therapies emerge for a progressive corneal disease

Current and future options for Fuchs endothelial corneal dystrophy



Dr Ben LaHood
Dr Ben LaHood

Latest:

Toric IOLs for beginners: What to consider before and during surgery and in the postoperative period

Giving due consideration to preoperative marking and the surgical technique in toric IOL implantation, as well as being diligent about reviewing postoperative results, can improve patient outcomes whilst minimising the chance of errors.


Dr Sachiko Kaidzu

Latest:

Leveraging UVC light for infection prevention in ophthalmology and beyond

The threshold limit value is increased for virus and bacterial eradication.


Francesc March de Ribot, MD, PhD, FEBO

Latest:

Considering cataract surgery and reduction of dementia in Europe

The procedure facilitates an independent life, better care and fewer costs.



Lynda Charters; Reviewed by Dr A. John Kanellopoulos

Latest:

AI enhances customised myopic LASIK with ray tracing optimisation

Customised myopic LASIK using automated ray tracing optimisation has the potential to offer improved and more predictable outcomes, a study shows.


Prof. Achim Langenbucher

Latest:

The 30-year history of optical coherence tomography of the human eye

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.


Cheryl Guttman Krader; Reviewed by Dr Albert J. Augustin

Latest:

DMO study shows robust efficacy of intravitreal dexamethasone implant

In a real-world study of patients with treatment-naïve and previously treated diabetic macular oedema, injection of intravitreal dexamethasone 0.7-mg implant provided effective disease control with initial and repeat injections, regardless of reinjection interval.


Jennifer Lim, MD, FARVO, FASRS

Latest:

Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DME

Dr Jennifer Lim presents two case studies demonstrating the application of the personalized treatment interval algorithm from the YOSEMITE and RHINE clinical trials for faricimab in DME.


Hattie Hayes; Reviewed by Sheng Lim, MD

Latest:

New MIGS devices aid patients and test patience

In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices


Louise Veenhuis

Latest:

ESCRS 2023: OWL brings more of the 'world' to Ophthalmic World Leaders

OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.


Robert C. Sergott, MD

Latest:

Fluorescence lifetime imaging ophthalmoscopy (FLIO) reveals the brain's best-kept secrets

FLIO ushers clinicians from structural to functional imaging, said Robert Sergott, MD, in a presentation at the International SPECTRALIS Symposium


Alper Bilgic, MD, FEBO

Latest:

Considering cataract surgery and reduction of dementia in Europe

The procedure facilitates an independent life, better care and fewer costs.


Lynda Charters; Reviewed by Paul Healey, PhD, MMed, MBBS(Hons), FRANZCO

Latest:

Considering the best surgical approach in angle closure patients

Intraocular drainage surgery in angle closure remains experimental and investigators are collecting data regarding its efficacy as well as adverse effects.



Dr Ashvini Reddy

Latest:

Exploring sustained drug delivery options in ophthalmology

Current options, challenges in developing novel therapies.

© 2025 MJH Life Sciences

All rights reserved.